Conditioning regimen and GvHD immuneprophylaxis
Conditioning regimens consisted of cyclophosphamide + total body irradiation (CY+TBI, n=28), busulfan + fludarabine ± rabbit antithymocyte globulin/alemtuzumab (BU+FLU±ATG/Alemtuzumab, n=22), CY±ATG (n=14), FLU+TBI (n=12), BU+CY (n=10), CY+FLU+TBI±ATG (n=8), CY+FLU±ATG (n=6), BU+FLU + melphalan ± ATG (n=5), other regimens (n=6). A total of 36 patients received serotherapy in conditioning regimen (ATG, n=35; Alemtuzumab, n=1). GVHD prophylaxis was based on cyclosporine + methotrexate (CsA+MTX, n=62, 56%), post-transplant cyclophosphamide + cyclosporine + mycophenolate mofetil (PT-Cy+CsA+MMF, n=31, 28%), CsA+MMF (n=12, 11%), and others (n=6, 5%).